Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia

The study team will assess the efficacy of platelet-rich plasma therapy, a special blood product which is from the participant's own body, in the treatment of androgenic alopecia (also known as male pattern hair loss) in females.

Inclusion Criteria: * Female ≥18 years of age at baseline visit. * Documentation of androgenic alopecia diagnosis as evidenced by one or more clinical features * Not currently on any treatment for alopecia, or has undergone 2-week washout period if recently on medication(s) for alopecia * Written informed consent obtained from subject and ability for subject to comply with the requirements of the study Exclusion Criteria: * Pregnant or breastfeeding * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data. * Have an infection, metastatic disease or certain skin conditions (ie. Psoriasis) which could worsen or spread with injections * Diagnosed with a blood or bleeding disorder * Diagnosed with anemia * Currently on anticoagulant therapy